What is nycomeds?

Nycomed is a global pharmaceutical company that focuses on the development and commercialization of differentiated pharmaceutical products in key therapeutic areas. The company was founded in Norway in 1984 and has since expanded its operations to over 50 countries around the world.

Nycomed's product portfolio includes medications for a variety of therapeutic areas, including gastroenterology, respiratory, pain management, and dermatology. The company is known for its innovative approach to drug development and its commitment to improving patient outcomes.

In 2011, Nycomed was acquired by Takeda Pharmaceutical Company, a leading Japanese pharmaceutical company, in a deal worth $13.7 billion. The acquisition expanded Takeda's global footprint and strengthened its presence in key markets, particularly in Europe.

Overall, Nycomed is known for its focus on research and development, its innovative approach to drug development, and its commitment to improving patient outcomes.